hormone receptor negative breast carcinoma
Showing 1 - 4 of 4
HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab
Recruiting
- HER2-positive Breast Cancer
- +17 more
- ALX148
- Fam-Trastuzumab Deruxtecan-Nxki
-
Chicago, Illinois
- +1 more
May 19, 2023
Male Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma Trial in Boston
Not yet recruiting
- Male Breast Cancer
- +2 more
- Tamoxifen
- +3 more
-
Boston, Massachusetts
- +1 more
Aug 12, 2022
HER2-positive Breast Cancer, HER2 Low, SYD-985 Trial in Aurora (Vic-trastuzumab duocarmazine (SYD985) + paclitaxel)
Recruiting
- HER2-positive Breast Cancer
- +26 more
- Vic-trastuzumab duocarmazine (SYD985) + paclitaxel
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Oct 22, 2021